GlassScriptPhysician profile
Lawrence M Arky
NPI 1124122338
$1,125.42
in general payments reported to CMS, 2019-2025
22 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $105 · 2021: $76.05 · 2022: $92.24 · 2023: $244 · 2024: $230 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $140.43 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $137.16 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $128.41 | 2019-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $81.49 | 2019-2025 | Gardasil 9, Gardasil |
| Organon LLC | $71.55 | 2022-2024 | Jada System |
| Abbvie INC. | $70.02 | 2019-2023 | Liletta |
| Therapeuticsmd, INC. | $66.99 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.89 | 2022-2024 | |
| Exact Sciences Corporation | $53.80 | 2025 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $46.63 | 2019 | |
| Minerva Surgical, INC | $37.02 | 2020-2024 | |
| Myovant Sciences INC. | $29.27 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $27.27 | 2023 | |
| Lupin INC. | $25.59 | 2019-2020 | |
| Ethicon US, LLC | $25.40 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $21.76 | 2024 | Mammomat Revelation |
| Covidien LP | $20.78 | 2019 | |
| Urovant Sciences INC | $20.39 | 2021 | |
| Sage Therapeutics, LLC | $19.16 | 2024 | |
| Vertical Pharmaceuticals, LLC | $13.51 | 2019 | |
| Avion Pharmaceuticals | $12.88 | 2019 | |
| Allergan, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Arky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.